NFKB1 and diabetes mellitus: Indeed, these findings have a potentially broader application as anti-inflammatory glucocorticoids repress NF-κB-regulated genes by directly interrupting the interaction of p65 with the basal transcription machinery [50], and glucocorticoid use in patients can cause diabetes, in part because of direct effects on beta cell insulin synthesis and secretion [51].